Join the club for FREE to access the whole archive and other member benefits.

Exercise hormone, irisin, protects brain from cognitive decline in mice

A novel therapeutic agent for treating Alzheimer's & neurodegenerative disorders

20-Aug-2021

Key points from article :

Irisin, secreted by the muscles during exercise, could be an effective therapeutic for addressing cognitive decline in Alzheimer’s disease.

In mouse models, genetic deletion of irisin impairs cognitive function in exercise, aging and Alzheimer’s.

Caused by alterations of newborn neurons in the hippocampus.

Elevating irisin levels in the blood improved cognitive function and neuroinflammation in mouse for Alzheimer’s disease.

“These effects can possibly go well beyond what exercise itself can bring,” - Christiane Wrann, senior author of the study.

Irisin was able to cross the blood-brain barrier and directly affect the brain.

Protects against neuroinflammation by acting directly on glia cells in the brain.

Treatment was effective in Alzheimer’s disease mouse models even after the development of significant pathology.

“...it could have beneficial effects on neurodegenerative diseases beyond just Alzheimer’s,” - Wrann.

Study by Massachusetts General Hospital published in Nature Metabolism.

Mentioned in this article:

Click on resource name for more details.

Christiane Wrann

Assistant Professor in Medicine at Massachusetts General Hospital and the Harvard Medical School

Massachusetts General Hospital (MGH)

Largest teaching hospital of Harvard Medical School located in Boston

Nature Metabolism

Online journal Nature Metabolism is an online journal of Nature Research

Topics mentioned on this page:
Exercise, Mental Health